Page last updated: 2024-08-26

imipenem, anhydrous and Body Weight

imipenem, anhydrous has been researched along with Body Weight in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, M; Kantesaria, B; Lala, M; Paschke, A; Rizk, ML; Walker, B1
Chen, W; Harris, G; Kanzaki, G; Kuo Lee, R; Lam, CK; Patel, GB; Xu, HH1
Andremont, A; Carbon, C; Massias, L; Montravers, P1
Hashimoto, Y; Inui, KI; Kokuryo, T; Nakamura, T1
Calandra, G; Carrigan, J; Guess, H; Lydick, E; Weiss, L1

Trials

2 trial(s) available for imipenem, anhydrous and Body Weight

ArticleYear
Simplification of Imipenem Dosing by Removal of Weight-Based Adjustments.
    Journal of clinical pharmacology, 2019, Volume: 59, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Renal Insufficiency; Young Adult

2019
Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.
    The American journal of medicine, 1988, Volume: 84, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; Body Weight; Central Nervous System Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Kidney Function Tests; Male; Regression Analysis; Retrospective Studies; Risk Factors; Seizures; Thienamycins; Time Factors; United States

1988

Other Studies

3 other study(ies) available for imipenem, anhydrous and Body Weight

ArticleYear
A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Vaccines; Body Weight; Bronchopneumonia; Disease Models, Animal; Female; Imipenem; Immunization; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Reproducibility of Results; Tigecycline; Time Factors

2013
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
    The Journal of infectious diseases, 1994, Volume: 169, Issue:4

    Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms

1994
Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
    The Journal of pharmacy and pharmacology, 1999, Volume: 51, Issue:2

    Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cilastatin; Cilastatin, Imipenem Drug Combination; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Drug Combinations; Fosfomycin; Glomerular Filtration Rate; Imipenem; Kidney; Male; Nitrogen; Rats; Rats, Wistar; Vancomycin; Weight Gain

1999